Merck & Co., Inc.·4

May 6, 5:16 PM ET

Fleming Michael 4

4 · Merck & Co., Inc. · Filed May 6, 2020

Insider Transaction Report

Form 4
Period: 2020-05-04
Fleming Michael
SVP Chief Ethics & Com Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-05-04$77.67/sh+692$53,7486,252.334 total
  • Tax Payment

    Common Stock

    2020-05-04$77.67/sh238$18,4856,014.334 total
  • Exercise/Conversion

    Restricted Stock Unit

    2020-05-051,2900 total
    From: 2020-05-05Exp: 2020-05-05Common Stock (1,290 underlying)
  • Exercise/Conversion

    Common Stock

    2020-05-05$76.86/sh+1,290$99,1497,304.334 total
  • Tax Payment

    Common Stock

    2020-05-05$76.86/sh458$35,2026,846.334 total
  • Exercise/Conversion

    Restricted Stock Unit

    2020-05-04692694 total
    From: 2019-05-04Exp: 2021-05-04Common Stock (692 underlying)
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
  • [F3]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT